CRISPRi screening identifies PIKfyve as a co-therapeutic target for obinutuzumab.
作者信息
Kim Yerim, Oh Jinkyung, Kim Jeong Ryeol, Lee Donghyuk, Kim Joo Young
机构信息
Department of Pharmacology and Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, Republic of Korea.
Woo Choo Lee Institute for Precision Drug Development, Seoul, Republic of Korea.
出版信息
Clin Transl Med. 2025 May;15(5):e70333. doi: 10.1002/ctm2.70333.
Abstract
摘要
Zotero 插件